DNM1L and cancer: Moreover, MHC-I expression level displayed a significant negative correlation with pSer616 DRP-1 expression level (Fig. 1D); high MHC-I expression level and low pSer616 DRP-1 expression level are both markers of significantly longer OS in the cancer patients tested (Fig. 1E).